2026-01-22 - Analysis Report
**Company Overview:**
Accenture plc is a global management consulting, technology services, and outsourcing company.

**Return Rate Comparison:**
* Review stock: ACN (Accenture) - Cumulative return: 2.30%
* Comparison stock: VOO (S&P 500) - Cumulative return: 91.55%
* Divergence: -89.00 (relative divergence: 10.80%)

The cumulative return of Accenture (ACN) is significantly lower than the S&P 500 (VOO), indicating a divergence of 89.00. This suggests that ACC has underperformed compared to the broader market.

**Alpha, Beta Analysis:**
| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|-----|-------|------|--------|
| 2016-2018 | 2.0% | 20.5% | -3.0% | 1.1 | 87.5B |
| 2017-2019 | 44.0% | 20.5% | 26.0% | 1.1 | 130.6B |
| 2018-2020 | 2.0% | 30.3% | -19.0% | 1.0 | 162.0B |
| 2019-2021 | 73.0% | 30.3% | 30.0% | 1.0 | 257.1B |
| 2020-2022 | -15.0% | 32.0% | -13.0% | 1.1 | 165.5B |
| 2021-2023 | 14.0% | 32.0% | 13.0% | 1.2 | 217.6B |
| 2022-2024 | -34.0% | 25.5% | -53.0% | 1.1 | 218.2B |
| 2023-2025 | -29.0% | 36.2% | -91.0% | 0.9 | 166.4B |

Analysis: Accenture's CAGR ranges from 2.0% to 73.0%, indicating varying levels of growth. The MDD (Maximum Drawdown) ranges from 20.5% to 36.2%, indicating varying levels of risk.

**Stock Price Fluctuations:**
* Close: $280.72
* Last-market: $280.72 (change: $2.94)
* 5-day SMA: $283.20
* 20-day SMA: $275.11
* 60-day SMA: $261.66

Analysis: The stock price has fluctuated recently, with a 5-day change of $2.94. The 20-day SMA is slightly higher than the current price, while the 60-day SMA is lower.

**RSI, PPO Index Indicators:**
* Market Risk Indicator (MRI): 0.80
* RSI: 56.96
* PPO: -0.06
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium
* Recent (20 days) relative divergence change: 2.00 (+)
* 7-day Rank change: 42 (+)
* 7-day Dynamic Expected Return change: -7.20 (-)

Analysis: The current Market Risk Indicator is 0.80, indicating a medium risk level. The RSI is at 56.96, indicating a moderate level of overbought or oversold conditions. The PPO is -0.06, indicating a negative momentum. The recent relative divergence change and 7-day rank change are positive, while the 7-day Dynamic Expected Return change is negative.

**Expected Return:**
* Expected Return (%): -167.50%

Analysis: The expected return is negative, indicating a potential loss in value.

**Recent News & Significant Events:**
See below for the news headlines:

1. Accenture stock jumps as "sovereign AI" data-center deal puts ACN back in focus - TechStockÂ² (news.google.com)
2. Vest Financial LLC Boosts Holdings in Accenture PLC $ACN - MarketBeat (news.google.com)
3. New 'sovereign AI' data centers to bolster Europe's digital resilience - Stock Titan (news.google.com)
4. Accenture Stock (ACN) Opinions on AI Revenue Surge and Digital Identity Partnership - Quiver Quantitative (news.google.com)

Analysis: Recent news highlights the company's focus on AI and its potential impact on the stock price.

**Analyst Opinions:**
* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 2.07 (~Buy)
	+ Opinions: 26
	+ Target Price (avg/high/low): 290.59 / 330.00 / 210.00

Analysis: Analysts have a consensus of "Buy" with a mean of 2.07, indicating a positive outlook. The target price range is between $290.59 and $330.00.

**Recent Earnings Analysis:**
| Date | EPS | Revenue |
|------|-----|---------|
| 2025-12-18 | 3.57 | $18.74B |
| 2025-10-10 | 2.27 | $17.60B |
| 2025-06-20 | 3.52 | $17.73B |
| 2025-10-10 | 3.52 | $17.73B |
| 2025-03-20 | 2.85 | $16.66B |

Analysis: Accenture's EPS has ranged from $2.27 to $3.57, while revenue has ranged from $16.66B to $18.74B.

**Financial Information - Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | $18.74B | 33.07% |
| 2025-08-31 | $17.60B | 31.89% |
| 2025-05-31 | $17.73B | 32.87% |
| 2025-02-28 | $16.66B | 29.86% |
| 2024-11-30 | $17.69B | 32.92% |

Analysis: Accenture's revenue has ranged from $16.66B to $18.74B, while profit margin has ranged from 29.86% to 33.07%.

**Financial Information - Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | $30.87B | 7.16% |
| 2025-08-31 | $31.20B | 4.53% |
| 2025-05-31 | $30.55B | 7.19% |
| 2025-02-28 | $29.25B | 6.11% |
| 2024-11-30 | $29.19B | 7.81% |

Analysis: Accenture's equity has ranged from $29.19B to $31.20B, while ROE has ranged from 4.53% to 7.81%.

**Comprehensive Analysis:**
Accenture's return rate has been significantly lower than the S&P 500, indicating a divergence of 89.00. The company's CAGR has ranged from 2.0% to 73.0%, while the MDD has ranged from 20.5% to 36.2%. The stock price has fluctuated recently, with a 5-day change of $2.94. The current Market Risk Indicator is 0.80, indicating a medium risk level. Analysts have a consensus of "Buy" with a mean of 2.07, indicating a positive outlook. Recent news highlights the company's focus on AI and its potential impact on the stock price.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.